Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in CSTL — Castle Biosciences Inc

CIK 1596800 VANCOUVER, A1

Position in CSTL

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$9,257,363
-$5,854,936 QoQ
Shares Held
377,082
-2.9% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $199,549,511 across 18 Diagnostics & Research names. CSTL ranks #6 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 CSTL
Castle Biosciences Inc
This page
377,082 $9,257,363

All Filings in CSTL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,257,363 377,082
2025-12-31 $15,112,299 388,491
2025-09-30 $7,648,238 335,891
2025-06-30 $2,581,721 126,431
2025-03-31 $3,541,317 176,889
2024-12-31 $4,496,201 168,713
2024-09-30 $4,718,862 165,458
2024-06-30 $1,456,129 66,887
2024-03-31 $1,720,102 77,657
2023-12-31 $1,911,340 88,570
2023-09-30 $1,361,080 80,585
2023-06-30 $844,397 61,545
2023-03-31 $958,375 42,182
2022-12-31 $662,509 28,144
2022-09-30 $602,213 23,091
2022-06-30 $427,212 19,463